文献速递肿瘤 PET/CT

[18F]氟脱氧葡萄糖PET/CT在评估鼻咽癌PD-L1状态中的价值

Usefulness of [18F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-01-03

本研究回顾性纳入84例初诊鼻咽癌患者,探讨18F-FDG摄取与肿瘤细胞(TCs)及肿瘤浸润免疫细胞(TIICs)PD-L1表达的关系。结果显示TCs中PD-L1表达与SUVmax和TLG正相关,而TIICs中PD-L1表达与SUVmax和血浆EBV载量负相关,提示18F-FDG PET/CT可能有助于评估鼻咽癌患者PD-L1状态。

要点

  • 肿瘤细胞PD-L1高表达与SUVmax(P=0.003)和TLG(P=0.001)正相关。
  • 肿瘤浸润免疫细胞PD-L1高表达与SUVmax(P=0.038)和血浆EBV载量(P=0.025)负相关。
  • 18F-FDG PET/CT可能有助于评估鼻咽癌患者PD-L1状态。

核心结论

  • 鼻咽癌病灶18F-FDG摄取与肿瘤细胞PD-L1表达正相关,与肿瘤浸润免疫细胞PD-L1表达负相关。
  • 因此18F-FDG PET/CT可能有助于评估鼻咽癌患者PD-L1状态。

研究设计与样本

  • 回顾性评估2016年12月至2019年3月间84例初诊鼻咽癌患者的记录,所有组织标本和PET/CT图像均在治疗前采集。
  • 肿瘤细胞和肿瘤浸润免疫细胞PD-L1高表达定义为≥50%染色细胞。

主要发现

  • 肿瘤细胞和肿瘤浸润免疫细胞的PD-L1状态间18F-FDG摄取存在显著差异。
  • 单因素分析显示肿瘤细胞PD-L1表达与SUVmax(P<0.001)、原发肿瘤TLG(P<0.001)和T分期(P=0.044)相关,但与血浆EBV载量无关(P=0.816)。
  • 肿瘤浸润免疫细胞PD-L1表达与SUVmax(P=0.011)、TLG(P=0.001)、T分期(P=0.028)和血浆EBV载量(P=0.003)相关。
  • 多因素logistic回归中,肿瘤细胞PD-L1表达与SUVmax(P=0.003)和TLG(P=0.001)正相关,肿瘤浸润免疫细胞PD-L1表达与SUVmax(P=0.038)和血浆EBV载量(P=0.025)负相关。

关键数值与推荐

  • 肿瘤细胞和肿瘤浸润免疫细胞PD-L1高表达定义为≥50%染色细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the relationship between [18F]fluorodeoxyglucose (18F-FDG uptake) and PD-L1 expression and determine the usefulness of 18F-FDG PET/CT for evaluating the PD-L1 status in tumour cells (TCs) and tumour-infiltrating immune cells (TIICs) in patients with nasopharyngeal carcinoma (NPC). METHODS: We retrospectively evaluated the records of 84 eligible patients who received an initial histopathological diagnosis of NPC between December 2016 and March 2019. All tissue specimens and PET/CT images were collected prior to treatment. High PD-L1 expression in TCs and TIICs was defined as ≥ 50% of stained cells. RESULTS: There was a significant difference in 18F-FDG uptake according to the PD-L1 status in TCs and TIICs. Univariate analysis showed that PD-L1 expression in TCs was associated with tumour maximum standardized uptake value (SUVmax) (P < 0.001), primary tumour total lesion glycolysis (TLG; P < 0.001), and T stage (P = 0.044), but not with plasma Epstein-Barr virus (EBV) load (P = 0.816), whereas PD-L1 expression in TIICs was related to SUVmax (P = 0.011), TLG (P = 0.001), T stage (P = 0.028), and plasma EBV load (P = 0.003). In multivariate logistic regression, PD-L1 expression in TCs was positively associated with SUVmax (P = 0.003) and TLG (P = 0.001), and in TIICs, negatively associated with SUVmax (P = 0.038) and plasma EBV load (P = 0.025). CONCLUSIONS: 18F-FDG uptake in NPC lesions was positively correlated with PD-L1 expression in TCs and negatively correlated with PD-L1 expression in TIICs. Thus, 18F-FDG PET/CT may be useful for evaluating the PD-L1 status in patients with NPC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhao L, Zhuang Y, Fu K, et al. Usefulness of [18F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2020. PMID: 31897588. doi:10.1007/s00259-019-04654-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。